Ehave Partner MedReleaf Files IPO

By April 19, 2017Industry News

Congratulations to Ehave partner MedReleaf on their proposed initial public offering. In February 2017, Ehave entered into a partnership with MedReleaf, Canada’s premium medical cannabis licensed producer, to advance the study and therapeutic use of medical cannabis. Ehave is working with MedReleaf to develop a branded app utilizing Ehave Connect, Ehave’s mental health informatics platform. Ehave Connect will enable developers, and ultimately prescribers of medical cannabis, to design and monitor treatment plans, track patient compliance, and verify treatment outcomes in a reliable and objective manner.